Dimerix Limited (DXB.AX)
AUD 0.32
(-5.88%)
AUD 0.32
(-5.88%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 32.07 Million AUD | 80.65% |
| 2023 | 17.75 Million AUD | 7.64% |
| 2022 | 16.49 Million AUD | 75.11% |
| 2021 | 9.42 Million AUD | -9.32% |
| 2020 | 10.38 Million AUD | 110.28% |
| 2019 | 4.94 Million AUD | -31.99% |
| 2018 | 7.26 Million AUD | 152.97% |
| 2017 | 2.87 Million AUD | 13.72% |
| 2016 | 2.52 Million AUD | -14.94% |
| 2015 | 2.96 Million AUD | 144.61% |
| 2014 | 1.21 Million AUD | -30.78% |
| 2013 | 1.75 Million AUD | 44.4% |
| 2012 | 1.21 Million AUD | -23.81% |
| 2011 | 1.59 Million AUD | -0.79% |
| 2010 | 1.6 Million AUD | 316.92% |
| 2009 | 385.33 Thousand AUD | -84.26% |
| 2008 | 2.44 Million AUD | -39.86% |
| 2007 | 4.07 Million AUD | 34.01% |
| 2006 | 3.03 Million AUD | -71.12% |
| 2005 | 10.52 Million AUD | 475.65% |
| 2004 | 1.82 Million AUD | 50.28% |
| 2003 | 1.21 Million AUD | -35.67% |
| 2002 | 1.89 Million AUD | -17.01% |
| 2001 | 2.27 Million AUD | -71.17% |
| 2000 | 7.9 Million AUD | -13.37% |
| 1999 | 9.12 Million AUD | -5.86% |
| 1998 | 9.68 Million AUD | 328.61% |
| 1997 | 2.26 Million AUD | 0.77% |
| 1996 | 2.24 Million AUD | 13.25% |
| 1995 | 1.98 Million AUD | -2.56% |
| 1994 | 2.03 Million AUD | 24.27% |
| 1993 | 1.63 Million AUD | 40.91% |
| 1992 | 1.16 Million AUD | 1.04% |
| 1991 | 1.14 Million AUD | -33.47% |
| 1990 | 1.72 Million AUD | -3.03% |
| 1989 | 1.78 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 15.08 Million AUD | 0.0% |
| 2024 Q4 | 32.07 Million AUD | 0.0% |
| 2024 FY | 32.07 Million AUD | 80.65% |
| 2023 Q4 | 17.75 Million AUD | 0.0% |
| 2023 Q2 | 6.35 Million AUD | 0.0% |
| 2023 FY | 17.75 Million AUD | 7.64% |
| 2022 FY | 16.49 Million AUD | 75.11% |
| 2022 Q2 | 20.53 Million AUD | 0.0% |
| 2022 Q4 | 16.49 Million AUD | 0.0% |
| 2021 Q2 | 5.01 Million AUD | 0.0% |
| 2021 Q4 | 9.42 Million AUD | 0.0% |
| 2021 FY | 9.42 Million AUD | -9.32% |
| 2020 Q2 | 4.04 Million AUD | 0.0% |
| 2020 FY | 10.38 Million AUD | 110.28% |
| 2020 Q4 | 10.38 Million AUD | 0.0% |
| 2019 FY | 4.94 Million AUD | -31.99% |
| 2019 Q4 | 4.94 Million AUD | 0.0% |
| 2019 Q2 | 5.42 Million AUD | 0.0% |
| 2018 FY | 7.26 Million AUD | 152.97% |
| 2018 Q4 | 7.26 Million AUD | 0.0% |
| 2018 Q2 | 1.19 Million AUD | 0.0% |
| 2017 FY | 2.87 Million AUD | 13.72% |
| 2017 Q2 | 1.51 Million AUD | 0.0% |
| 2017 Q4 | 2.87 Million AUD | 0.0% |
| 2016 Q4 | 2.52 Million AUD | 0.0% |
| 2016 FY | 2.52 Million AUD | -14.94% |
| 2016 Q2 | 2.78 Million AUD | 0.0% |
| 2015 Q3 | 696.52 Thousand AUD | 0.0% |
| 2015 Q4 | 2.96 Million AUD | 326.22% |
| 2015 FY | 2.96 Million AUD | 144.61% |
| 2014 Q4 | 1.21 Million AUD | 0.0% |
| 2014 FY | 1.21 Million AUD | -30.78% |
| 2013 Q4 | 1.75 Million AUD | 0.0% |
| 2013 FY | 1.75 Million AUD | 44.4% |
| 2012 Q4 | 1.21 Million AUD | 0.0% |
| 2012 FY | 1.21 Million AUD | -23.81% |
| 2011 FY | 1.59 Million AUD | -0.79% |
| 2011 Q4 | 1.59 Million AUD | 0.0% |
| 2010 FY | 1.6 Million AUD | 316.92% |
| 2010 Q4 | 1.6 Million AUD | 0.0% |
| 2009 FY | 385.33 Thousand AUD | -84.26% |
| 2009 Q4 | 385.33 Thousand AUD | 0.0% |
| 2008 Q4 | 2.44 Million AUD | 0.0% |
| 2008 FY | 2.44 Million AUD | -39.86% |
| 2007 Q4 | 4.07 Million AUD | 0.0% |
| 2007 FY | 4.07 Million AUD | 34.01% |
| 2006 FY | 3.03 Million AUD | -71.12% |
| 2006 Q4 | 3.03 Million AUD | 0.0% |
| 2005 Q4 | 10.52 Million AUD | 0.0% |
| 2005 FY | 10.52 Million AUD | 475.65% |
| 2004 Q4 | 1.82 Million AUD | 0.0% |
| 2004 FY | 1.82 Million AUD | 50.28% |
| 2003 Q4 | 1.21 Million AUD | 0.0% |
| 2003 FY | 1.21 Million AUD | -35.67% |
| 2002 FY | 1.89 Million AUD | -17.01% |
| 2002 Q4 | 1.89 Million AUD | 0.0% |
| 2001 FY | 2.27 Million AUD | -71.17% |
| 2001 Q4 | 2.27 Million AUD | 0.0% |
| 2000 Q4 | 7.9 Million AUD | 0.0% |
| 2000 FY | 7.9 Million AUD | -13.37% |
| 1999 FY | 9.12 Million AUD | -5.86% |
| 1999 Q4 | 9.12 Million AUD | 0.0% |
| 1998 FY | 9.68 Million AUD | 328.61% |
| 1997 Q4 | 2.26 Million AUD | 0.0% |
| 1997 FY | 2.26 Million AUD | 0.77% |
| 1996 FY | 2.24 Million AUD | 13.25% |
| 1995 FY | 1.98 Million AUD | -2.56% |
| 1994 FY | 2.03 Million AUD | 24.27% |
| 1993 FY | 1.63 Million AUD | 40.91% |
| 1992 FY | 1.16 Million AUD | 1.04% |
| 1991 FY | 1.14 Million AUD | -33.47% |
| 1990 FY | 1.72 Million AUD | -3.03% |
| 1989 FY | 1.78 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 25.55 Million AUD | -25.542% |
| Anatara Lifesciences Ltd | 1.67 Million AUD | -1819.237% |
| Zelira Therapeutics Limited | 5.18 Million AUD | -518.869% |
| Biome Australia Limited | 8.27 Million AUD | -287.572% |
| Patrys Limited | 4.16 Million AUD | -670.826% |
| Orthocell Limited | 26.61 Million AUD | -20.527% |
| Imugene Limited | 151.39 Million AUD | 78.812% |
| Noxopharm Limited | 6.78 Million AUD | -372.873% |
| PYC Therapeutics Limited | 91.23 Million AUD | 64.841% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | -110.032% |
| Prescient Therapeutics Limited | 20.39 Million AUD | -57.303% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | -194.972% |
| Cynata Therapeutics Limited | 8.38 Million AUD | -282.421% |
| CSL Limited | 56.93 Billion AUD | 99.944% |
| Arovella Therapeutics Limited | 13.28 Million AUD | -141.47% |
| Bio-Gene Technology Limited | 3.15 Million AUD | -915.276% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 86.121% |
| Starpharma Holdings Limited | 36.81 Million AUD | 12.863% |
| Nanollose Limited | 241.95 Thousand AUD | -13158.283% |
| Memphasys Limited | 12.43 Million AUD | -158.071% |
| Invex Therapeutics Ltd | 6.12 Million AUD | -424.155% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -490.127% |
| Amplia Therapeutics Limited | 14.84 Million AUD | -116.088% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 71.477% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | -1150.884% |
| Race Oncology Limited | 20.22 Million AUD | -58.58% |
| Nyrada Inc. | 5.9 Million AUD | -443.036% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 91.946% |
| PharmAust Limited | 11.12 Million AUD | -188.35% |
| Immutep Limited | 147.44 Million AUD | 78.244% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 79.255% |
| Alterity Therapeutics Limited | 19.22 Million AUD | -66.869% |
| BTC Health Limited | 5.14 Million AUD | -523.029% |
| Acrux Limited | 8.96 Million AUD | -257.9% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 87.064% |
| Biotron Limited | 493.47 Thousand AUD | -6400.529% |
| Tissue Repair Ltd | 19.38 Million AUD | -65.442% |
| AdAlta Limited | 5.57 Million AUD | -475.606% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 55.469% |
| Hexima Limited | 2.26 Million AUD | -1313.772% |
| AnteoTech Limited | 9.38 Million AUD | -241.946% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -17.116% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | -403.618% |
| Avecho Biotechnology Limited | 7.31 Million AUD | -338.273% |
| Actinogen Medical Limited | 21.31 Million AUD | -50.52% |
| Immuron Limited | 15.54 Million AUD | -106.293% |
| Argenica Therapeutics Limited | 16.37 Million AUD | -95.869% |